Ocugenix Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4M

  • Investors
  • 2

Ocugenix General Information

Description

Developer of disease-modifying ophthalmic therapies intended to treat angiofibrotic diseases of the eye. The company offers wet macular degeneration therapies, geographic atrophy treatments, proliferative diabetic retinopathy drugs, dry eye disease therapeutics, and ocular small molecule candidates, enabling patients to restore homeostatic function and prevent vision loss by activating natural wound-healing processes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 79 Woodland Road
  • Pittsburgh, PA 15232
  • United States
+1 (412)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 79 Woodland Road
  • Pittsburgh, PA 15232
  • United States
+1 (412)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ocugenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 21-Mar-2022 $4M Completed Clinical Trials - Phase 2
1. Seed Round 29-Mar-2017 Completed Clinical Trials - Phase 2
To view Ocugenix’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ocugenix Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mountain State Capital Venture Capital Minority
Innovation Works Venture Capital Minority
To view Ocugenix’s complete investors history, request access »

Ocugenix FAQs

  • When was Ocugenix founded?

    Ocugenix was founded in 2015.

  • Where is Ocugenix headquartered?

    Ocugenix is headquartered in Pittsburgh, PA.

  • What industry is Ocugenix in?

    Ocugenix’s primary industry is Drug Discovery.

  • Is Ocugenix a private or public company?

    Ocugenix is a Private company.

  • What is Ocugenix’s current revenue?

    The current revenue for Ocugenix is .

  • How much funding has Ocugenix raised over time?

    Ocugenix has raised $4.1M.

  • Who are Ocugenix’s investors?

    Mountain State Capital and Innovation Works have invested in Ocugenix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process